Tender detail
Open-house discount agreements for medicines containing nintedanib, ATC L01EX09
Summary
The procurement concerns non-exclusive discount agreements for medicines containing the active substance nintedanib, under an open-house model that allows agreements to be concluded at any time between 1 May 2026 and 30 April 2028. Medicines listed as paediatric medicines under section 35(5a) of the German Social Code Book V are excluded.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.